Limitations of employing antibody drug conjugates (ADCs) for targeting HIV infected cells as a strategy for hiv cure
Main Authors: | J. Strizki, D. Graham, M. Lu, G. Wu, M. Breslin, N. Davis, E. Escandon, L. Fayadat-Dilman, Y. Zheng, R. Barnard, R. Garbaccio, A. Manibusan, S. Bhowmik, D. Gately, Y. Sun, D. Gorman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020314084 |
Similar Items
-
Pathways to HIV cure
by: D. Persaud
Published: (2014-04-01) -
Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
by: Jeffrey C. Umotoy, et al.
Published: (2021-07-01) -
A mechanistic modelling platform for HIV cure drug development
by: Y. Cao, et al.
Published: (2019-12-01) -
Perceptions of HIV cure research among people living with HIV in Australia.
by: Jennifer Power, et al.
Published: (2018-01-01) -
Addressing an HIV cure in LMIC
by: Sherazaan D. Ismail, et al.
Published: (2021-08-01)